Monoclonal antibodies raised to the human FOXP3 protein can be used effectively for detecting Foxp3(+) T cells in other mammalian species. von Banham, A, Lyne, L, Scase, T, Blacklaws, B

Is FOXP3 expressed in cutaneous T-cell lymphomas? von Banham, A, Brown, P, Lyne, L, Schulze, H, Hallermann, C

The NFIL3 transcription factor is preferentially expressed in BCR-independent mature B-cell malignancy von Gascoyne, D, Lyne, L, Spearman, H, Soilleux, E, Banham, A

Vitamin D receptor expression in plasmablastic lymphoma and myeloma cells confers susceptibility to vitamin D von Gascoyne, D, Lyne, L, Spearman, H, Buffa, F, Soilleux, E, Banham, A

Expression of FOXP2 is up-regulated in lymphoid malignancies von Campbell, A, Lyne, L, Brown, P, Launchbury, R, Chi, J, Roncador, G, Lawrie, C, Kusec, R, Banham, A

The forkhead transcription factor FOXP2 is required for regulation of p21WAF1/CIP1 in 143B osteosarcoma cell growth arrest von Gascoyne, DM, Spearman, H, Lyne, L, Puliyadi, R, Perez-Alcantara, M, Coulton, L, Fisher, SE, Croucher, PI, Banham, AH

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures von Wong, K, Gascoyne, D, Soilleux, E, Lyne, L, Spearman, H, Banham, A, Roncador, G, Pedersen, L, Moller, M, Green, T

Frequent gains of REL and BCL11A in mediastinal B-cell lymphoma selectively provoke up-regulated RNA and protein expression von Weniger, M, Pulford, K, Gesk, S, Ehrlich, S, Banham, A, Lyne, L, Martin-Subero, J, Siebert, R, Dyer, M, Moeller, P, Barth, T

FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas von Brown, P, Wong, K, Felce, S, Lyne, L, Spearman, H, Soilleux, E, Pedersen, L, Møller, M, Green, T, Gascoyne, D, Banham, A

Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. von Weniger, M, Pulford, K, Gesk, S, Ehrlich, S, Banham, A, Lyne, L, Martin-Subero, J, Siebert, R, Dyer, M, Möller, P, Barth, T

Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells. von Campbell, A, Lyne, L, Brown, P, Launchbury, R, Bignone, P, Chi, J, Roncador, G, Lawrie, C, Gatter, K, Kusec, R, Banham, A

N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells. von Brown, P, Gascoyne, D, Lyne, L, Spearman, H, Felce, S, McFadden, N, Chakravarty, P, Barrans, S, Lynham, S, Calado, D, Ward, M, Banham, A

Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells: Research paper von Campbell, A, Lyne, L, Brown, P, Launchbury, R, Bignone, P, Chi, J, Roncador, G, Lawrie, C, Gatter, K, Kusec, R, Banham, A

FMIP controls the adipocyte lineage commitment of C2C12 cells by downmodulation of C/EBP alpha. von Mancini, A, El Bounkari, O, Norrenbrock, A, Scherr, M, Schaefer, D, Eder, M, Banham, A, Pulford, K, Lyne, L, Whetton, A, Tamura, T

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients von Wong, K, Gascoyne, D, Brown, P, Soilleux, E, Snell, C, Chen, H, Lyne, L, Lawrie, C, Gascoyne, R, Pedersen, L, Møller, M, Pulford, K, Murphy, D, Green, T, Banham, A

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients. von Wong, K, Gascoyne, D, Brown, P, Soilleux, E, Snell, C, Chen, H, Lyne, L, Lawrie, C, Gascoyne, R, Pedersen, L, Møller, M, Pulford, K, Murphy, D, Green, T, Banham, A

The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells. von Pulford, K, Banham, A, Lyne, L, Jones, M, Ippolito, G, Liu, H, Tucker, P, Roncador, G, Lucas, E, Ashe, S, Stockwin, L, Walewska, R, Karran, L, Gascoyne, R, Mason, D, Dyer, M